Robert E. Hoffman - Apr 1, 2025 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
Apr 1, 2025
Transactions value $
$0
Form type
4
Date filed
4/2/2025, 04:19 PM
Previous filing
Jan 6, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +40K $0.00 40K Apr 1, 2025 Common Stock 40K $1.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards vest over a three (3) year period in equal annual installments the first of which will be April 1, 2026.